Turgay Yildirim

Turgay Yildirim

Auto-generated profile, based on publicly available information

Turgay Yildirim

HIPS − Helmholtz Institute for Pharmaceutical Research Saarland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2024 in Small
Verified
Journal Article
Open access
TYTurgay Yildirim
Turgay Yildirim
ABAghiad Bali
Aghiad Bali
MKMarcus Koch
Marcus Koch
PPPascal Paul
Pascal Paul
LLLorenz Latta
Lorenz Latta
CLClaus‐Michael Lehr
Claus‐Michael Lehr
Pseudomonas aeruginosa (PA) is a major healthcare concern due to its tolerance to antibiotics when enclosed in biofilms. Tobramycin (Tob), an effective cationic aminoglycoside antibiotic against planktonic PA, loses potency within PA biofilms due to hindered diffusion caused by interactions with anionic biofilm components. Loading Tob into nano‐carriers can enhance its biofilm efficacy by shielding its charge. Polyion complex vesicles (PIC‐somes) are promising nano‐carriers for charged drugs, allowing higher drug loadings than liposomes and polymersomes. In this study, a new class of nano‐sized PIC‐somes, formed by Tob‐diblock copolymer complexation is presented. This approach replaces conventional linear PEG with brush‐like poly[ethylene glycol (methyl ether methacrylate)] (PEGMA) in the shell‐forming block, distinguishing it from past methods. Tob paired with a block copolymer containing hydrophilic PEGMA induces micelle formation (PIC‐micelles), while incorporating hydrophobic pyridyldisulfide ethyl methacrylate (PDSMA) monomer into PEGMA chains reduces shell hydrophilicity, leads to the formation of vesicles (PIC‐somes). PDSMA unit incorporation enables unprecedented dynamic disulfide bond‐based shell cross‐linking, significantly enhancing stability under saline conditions. Neither PIC‐somes nor PIC‐micelles show any relevant cytotoxicity on A549, Calu‐3, and dTHP‐1 cells. Tob's antimicrobial efficacy against planktonic PA remains unaffected after encapsulation into PIC‐somes and PIC‐micelles, but its potency within PA biofilms significantly increases.


10 September 2026 in ACS Polymers Au
Verified
Journal Article
Open access
TYTurgay Yildirim
Turgay Yildirim
ABAnnette Boese
Annette Boese
ABAghiad Bali
Aghiad Bali
MKMarcus Koch
Marcus Koch
MKMax G. Koumou-Okandze
Max G. Koumou-Okandze
CLClaus-Michael Lehr
Claus-Michael Lehr
Polymer conjugation of cationic antibiotics has emerged as a promising strategy to improve their pharmacological properties and enhance their performance in biofilm-associated infections. Herein, we investigate the effect of poly[oligo(ethylene glycol) methyl ether methacrylate] (POEGMA) side-chain length on the physicochemical properties, antimicrobial activity, and biocompatibility of tobramycin (Tob)-POEGMA conjugates. Three alkyne-functional POEGMA copolymers with different oligo(ethylene glycol) side-chain lengths were synthesized by reversible addition–fragmentation chain-transfer (RAFT) polymerization, and subsequently conjugated to azide-functional Tob via Cu(I)-catalyzed azide–alkyne cycloaddition. The aqueous solution behavior of the resulting conjugates was strongly dependent on side-chain length: the polymer bearing the longest side chains remained dissolved, whereas conjugates with shorter side chains self-assembled into positively charged nanoparticles. Antimicrobial evaluation against Pseudomonas aeruginosa PAO1 revealed that decreasing the POEGMA side-chain length enhanced antimicrobial activity, with the shortest-side-chain formulation exhibiting the lowest MIC90 value among the polymer conjugates. However, increased antimicrobial activity was accompanied by increased cytotoxicity toward A549 and Calu-3 epithelial cells. In contrast, longer POEGMA side-chains effectively shielded the cationic Tob residues, resulting in improved biocompatibility but reduced antimicrobial efficacy. These findings demonstrate that POEGMA side-chain length governs the balance between antimicrobial activity and cytocompatibility in Tob-POEGMA conjugates. The results further suggest that long-chain POEGMA represents a promising platform for biofilm-targeted antibiotic delivery when combined with infection-responsive linkers capable of releasing the active antibiotic at the site of infection.